Discover 998 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 998
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
for
Pouchitis, Pouches, Ileoanal, Pouch, Ileal
Location: Rochester MN, Chapel Hill NC, New York NY,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70+
Code: NCT06864403
Recruiting
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
for
Bladder Urothelial Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07029256
Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Rochester MN, Albert Lea MN, La Crosse WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase3, Recruiting
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
for
Metastatic Bladder Urothelial Carcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07087860
Phase2, Recruiting
Diagnosing Epilepsy To EffeCT Change
for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Rochester MN, Minneapolis MN, St Louis MO,
Sponsor: Epiminder America, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07110337
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
for
Lung Cancer, Lung Metastases
Location: Rochester MN, Ann Arbor MI, Aurora CO, Philadelphia PA,
Sponsor: Vergent Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07499674
Phase3, Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Rochester MN, Chicago IL, Kansas City MO,
Sponsor: Intellia Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06128629
Phase3, Recruiting
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
for
Lupus Nephritis (LN)
Location: Rochester MN, Houston TX, San Francisco CA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 60
Code: NCT06975787
Phase1, Recruiting
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
for
Heart Failure With Preserved Ejection Fraction,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07093528
Recruiting
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
for
Endometrial Carcinoma, Prostate Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07407959
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Rochester MN, Norton Shores MI, Grand Rapids MI,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase1, Recruiting
Clinical and Molecular Characteristics of Histiocytic Disorders
for
Histiocytic Disorder
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 1+
Code: NCT06331377
Recruiting
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
for
Breast Carcinoma
Location: Rochester MN, Indianapolis IN, Chapel Hill NC,
Sponsor: Mayo Clinic
Sex: Female
Age: 18 - 45
Code: NCT05557877
Phase2, Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Location: Rochester MN, Chicago IL, Kansas City KS, Ann Arbor MI,
Sponsor: Cabaletta Bio
Sex: All
Age: 18 - 70+
Code: NCT06328777
Phase2, Phase3, Recruiting
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04892277
Phase1, Recruiting
Mucosal and Microbiota Changes During Acute Campylobacteriosis
for
Irritable Bowel Syndrome
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70+
Code: NCT03223077
Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Rochester MN, Saint Paul MN, Eau Claire WI, Edina MN,